These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 36928556)
1. Distribution of [ Kang MS; Hamadjida A; Bédard D; Nuara SG; Gourdon JC; Frey S; Aliaga A; Ross K; Hopewell R; Bdair H; Mathieu A; Tardif CL; Soucy JP; Massarweh G; Rosa-Neto P; Huot P Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):2095-2103. PubMed ID: 36928556 [TBL] [Abstract][Full Text] [Related]
2. What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2. Leurquin-Sterk G; Celen S; Van Laere K; Koole M; Bormans G; Langlois X; Van Hecken A; Te Riele P; Alcázar J; Verbruggen A; de Hoon J; Andrés JI; Schmidt ME J Nucl Med; 2017 Jan; 58(1):110-116. PubMed ID: 27469358 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and preliminary studies of Zhang X; Zhang Y; Chen Z; Shao T; Van R; Kumata K; Deng X; Fu H; Yamasaki T; Rong J; Hu K; Hatori A; Xie L; Yu Q; Ye W; Xu H; Sheffler DJ; Cosford NDP; Shao Y; Tang P; Wang L; Zhang MR; Liang SH Theranostics; 2020; 10(24):11178-11196. PubMed ID: 33042277 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of JNJ-40068782, a new potent, selective, and systemically active positive allosteric modulator of the mGlu2 receptor and its radioligand [3H]JNJ-40068782. Lavreysen H; Langlois X; Ahnaou A; Drinkenburg W; te Riele P; Biesmans I; Van der Linden I; Peeters L; Megens A; Wintmolders C; Cid JM; Trabanco AA; Andrés JI; Dautzenberg FM; Lütjens R; Macdonald G; Atack JR J Pharmacol Exp Ther; 2013 Sep; 346(3):514-27. PubMed ID: 23766542 [TBL] [Abstract][Full Text] [Related]
5. PET brain imaging of neuropeptide Y2 receptors using N-11C-methyl-JNJ-31020028 in pigs. Winterdahl M; Audrain H; Landau AM; Smith DF; Bonaventure P; Shoblock JR; Carruthers N; Swanson D; Bender D J Nucl Med; 2014 Apr; 55(4):635-9. PubMed ID: 24614224 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological and pharmacokinetic properties of JNJ-40411813, a positive allosteric modulator of the mGlu2 receptor. Lavreysen H; Ahnaou A; Drinkenburg W; Langlois X; Mackie C; Pype S; Lütjens R; Le Poul E; Trabanco AA; Nuñez JM Pharmacol Res Perspect; 2015 Feb; 3(1):e00096. PubMed ID: 25692015 [TBL] [Abstract][Full Text] [Related]
8. Identification and Development of a New Positron Emission Tomography Ligand 4-(2-Fluoro-4-[ Yamasaki T; Zhang X; Kumata K; Zhang Y; Deng X; Fujinaga M; Chen Z; Mori W; Hu K; Wakizaka H; Hatori A; Xie L; Ogawa M; Nengaki N; Van R; Shao Y; Sheffler DJ; Cosford NDP; Liang SH; Zhang MR J Med Chem; 2020 Oct; 63(20):11469-11483. PubMed ID: 32960052 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and Preliminary Studies of a Novel Negative Allosteric Modulator, 7-((2,5-Dioxopyrrolidin-1-yl)methyl)-4-(2-fluoro-4-[ Zhang X; Kumata K; Yamasaki T; Cheng R; Hatori A; Ma L; Zhang Y; Xie L; Wang L; Kang HJ; Sheffler DJ; Cosford NDP; Zhang MR; Liang SH ACS Chem Neurosci; 2017 Sep; 8(9):1937-1948. PubMed ID: 28565908 [TBL] [Abstract][Full Text] [Related]
10. PET Imaging of the P2X7 Ion Channel with a Novel Tracer [ Berdyyeva T; Xia C; Taylor N; He Y; Chen G; Huang C; Zhang W; Kolb H; Letavic M; Bhattacharya A; Szardenings AK Mol Imaging Biol; 2019 Oct; 21(5):871-878. PubMed ID: 30632003 [TBL] [Abstract][Full Text] [Related]
11. Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates. Ory D; Celen S; Gijsbers R; Van Den Haute C; Postnov A; Koole M; Vandeputte C; Andrés JI; Alcazar J; De Angelis M; Langlois X; Bhattacharya A; Schmidt M; Letavic MA; Vanduffel W; Van Laere K; Verbruggen A; Debyser Z; Bormans G J Nucl Med; 2016 Sep; 57(9):1436-41. PubMed ID: 27199364 [TBL] [Abstract][Full Text] [Related]
12. Preclinical evaluation of the antipsychotic potential of the mGlu2-positive allosteric modulator JNJ-40411813. Lavreysen H; Langlois X; Donck LV; Nuñez JM; Pype S; Lütjens R; Megens A Pharmacol Res Perspect; 2015 Mar; 3(2):e00097. PubMed ID: 25692027 [TBL] [Abstract][Full Text] [Related]
13. The [18F]FDG μPET readout of a brain activation model to evaluate the metabotropic glutamate receptor 2 positive allosteric modulator JNJ-42153605. Wyckhuys T; Wyffels L; Langlois X; Schmidt M; Stroobants S; Staelens S J Pharmacol Exp Ther; 2014 Aug; 350(2):375-86. PubMed ID: 24898267 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of mGlu Metcalf CS; Klein BD; Smith MD; Pruess T; Ceusters M; Lavreysen H; Pype S; Van Osselaer N; Twyman R; White HS Epilepsia; 2017 Mar; 58(3):484-493. PubMed ID: 28166368 [TBL] [Abstract][Full Text] [Related]
15. mGlu2 Receptor Agonism, but Not Positive Allosteric Modulation, Elicits Rapid Tolerance towards Their Primary Efficacy on Sleep Measures in Rats. Ahnaou A; Lavreysen H; Tresadern G; Cid JM; Drinkenburg WH PLoS One; 2015; 10(12):e0144017. PubMed ID: 26658273 [TBL] [Abstract][Full Text] [Related]
19. Marmoset Serotonin 5-HT1A Receptor Mapping with a Biased Agonist PET Probe 18F-F13714: Comparison with an Antagonist Tracer 18F-MPPF in Awake and Anesthetized States. Yokoyama C; Mawatari A; Kawasaki A; Takeda C; Onoe K; Doi H; Newman-Tancredi A; Zimmer L; Onoe H Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27608810 [TBL] [Abstract][Full Text] [Related]